資源 » 參考數據庫 » 客戶發表文獻

至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫藥類雜志引用近萬次，處于行業領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發表科研成果，再次證明GenScript 有能力幫助業內科學家Make research easy.

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

Cancer Cell. 2022-05;

Robert Stuver, Gunjan L Shah, Neha S Korde, Lindsey E Roeker, Anthony R Mato, Connie L Batlevi, David J Chung, Sital Doddi, Lorenzo Falchi, Boglarka Gyurkocza, Audrey Hamilton, Ya-Hui Lin, Ann A Jakubowski, Erel Joffe, Heather L Landau, Richard J Lin, Sham Mailankody, M Lia Palomba, Jae H Park, Miguel-Angel Perales, Doris M Ponce, Lakshmi V Ramanathan, Gilles A Salles, Michael Scordo, Susan K Seo, Urvi A Shah, Eytan M Stein, David Straus, Saad Z Usmani, James W Young, Andrew D Zelenetz, Ariela Noy, Santosha A Vardhana

Products/Services Used	Details	Operation
Recombinant Proteins	… Virus neutralization was measured using the SARSCoV-2 surrogate virus neutralization test kit (Genscript), and percent inhibition was calculated per manufacturer’s instructions with a …	Get A Quote